Invasive Staphylococcus aureus Infection among Patients Undergoing Elective, Posterior, Instrumented Spinal Fusion Surgeries: A Retrospective Cohort Study.

Background: Post-surgical invasive Staphylococcus aureus infections among spinal fusion patients are serious complications that can worsen clinical outcomes and increase healthcare utilization. Risk of such infections at the population level remains unknown. This study assessed the post-surgical risk of invasive Staphylococcus aureus infections among patients undergoing elective posterior instrumented spinal fusion surgeries in 129 U.S. hospitals. Patients and Methods: This retrospective cohort study analyzed adult patients ≥18 years of age who underwent thoracolumbar/lumbar and cervical fusion surgeries during 2010 - 2014 using the Premier Healthcare Database, the largest hospital discharge database in the United States. Risks of blood stream infection (BSI), deep or organ/space surgical site infections (SSI) caused by Staphylococcus aureus during 90 and 180 days post-index surgery were estimated. Infections were identified based on positive culture results, related International Classification of Diseases, Ninth Revision (ICD-9) procedure codes, and specific claims information. Results: Among 11,236 patients with thoracolumbar/lumbar fusion, 90- and 180-day BSI/SSI infection risks were higher for multilevel than single level fusion (90-day, 1.52% vs. 1.07%, p = 0.05; 180-day, 1.66% vs. 1.07%, p = 0.014). Among 1,641 patients with cervical fusion, 90- and 180-day BSI/SSI infection risks were also higher in multilevel fusions but not statistically significant (90-day, 1.66% vs. 0.52%, p = 0.350; 180-day, 1.80% vs. 0.51%, p = 0.241). The risk for SSI/BSI was more than twice as high among multilevel thoracolumbar/lumbar fusion patients with more than two comorbidities than those with no comorbidity at both 90-day (2.78% vs. 1.00%, p < 0.05) and 180-day (3.01% vs. 1.10%, p < 0.05). Similar trend without statistical significance was seen in multilevel cervical fusion cohort (90-day, 2.91% vs. 1.25%, p > 0.05; 180-day, 3.88% vs. 1.41%, p > 0.05). Conclusions: The risk of BSI/SSI infection for elective posterior instrumented spinal fusions ranged between 0.5% and 2%. Higher risk was observed in multilevel thoracolumbar/lumbar surgery, with infection risk greatest in patients with more than two comorbidities. These real-world findings highlight the need for additional measures, in addition to antibiotic prophylaxis, to reduce invasive Staphylococcus aureus infections in this setting.

[1]  A. Dagal,et al.  Body mass index and the risk of deep surgical site infection following posterior cervical instrumented fusion. , 2018, The spine journal : official journal of the North American Spine Society.

[2]  E. P. Dellinger,et al.  Introduction to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee Guideline for the Prevention of Surgical Site Infections. , 2017, Surgical infections.

[3]  H. Khoury,et al.  Burden of Surgical Site Infections Associated with Select Spine Operations and Involvement of Staphylococcus aureus , 2017, Surgical infections.

[4]  D. Flum,et al.  Intra-Wound Antibiotics and Infection in Spine Fusion Surgery: A Report from Washington State's SCOAP-CERTAIN Collaborative. , 2016, Surgical infections.

[5]  Z. Gokaslan,et al.  Deep-wound and organ-space infection after surgery for degenerative spine disease: an analysis from 2006 to 2012 , 2016, Neurological research.

[6]  S. E. Ames,et al.  A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion , 2016, Pharmacotherapy.

[7]  D. Ahn,et al.  Particular Features of Surgical Site Infection in Posterior Lumbar Interbody Fusion , 2015, Clinics in orthopedic surgery.

[8]  M. Bhandari,et al.  Intrawound vancomycin to prevent infections after spine surgery: a systematic review and meta-analysis , 2015, European Spine Journal.

[9]  Shih-Hao Chen,et al.  Postoperative wound infection after posterior spinal instrumentation: analysis of long-term treatment outcomes , 2015, European Spine Journal.

[10]  D. Polly,et al.  Cost savings analysis of intrawound vancomycin powder in posterior spinal surgery. , 2014, The spine journal : official journal of the North American Spine Society.

[11]  G. Zaloga,et al.  A retrospective, observational study of patient outcomes for critically ill patients receiving parenteral nutrition. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  Sang Gu Lee,et al.  Prophylactic Intrawound Application of Vancomycin Powder in Instrumented Spinal Fusion Surgery , 2013, Korean Journal of Spine.

[13]  Frank X Liu,et al.  Bloodstream infections in patients receiving manufactured parenteral nutrition with vs without lipids: is the use of lipids really deleterious? , 2012, JPEN. Journal of parenteral and enteral nutrition.

[14]  A. Gerometta,et al.  Infections in spinal instrumentation , 2012, International Orthopaedics.

[15]  Jeffrey G Jarvik,et al.  Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. , 2010, JAMA.

[16]  R. Deyo,et al.  Complications and Mortality Associated With Cervical Spine Surgery for Degenerative Disease in the United States , 2007, Spine.

[17]  R. Deyo,et al.  United States Trends in Lumbar Fusion Surgery for Degenerative Conditions , 2005, Spine.